Format
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 4

1.

Antigenic evidence of prevalence and diversity of Mycobacterium tuberculosis arabinomannan.

Glatman-Freedman A, Casadevall A, Dai Z, Jacobs WR Jr, Li A, Morris SL, Navoa JA, Piperdi S, Robbins JB, Schneerson R, Schwebach JR, Shapiro M.

J Clin Microbiol. 2004 Jul;42(7):3225-31.

2.

Use of Pseudomonas aeruginosa toxin A in the construction of conjugate vaccines and immunotoxins.

Cryz SJ Jr, F├╝rer E, Sadoff JC, Germanier R, Pastan I, Willingham MC, FitzGerald DJ.

Rev Infect Dis. 1987 Sep-Oct;9 Suppl 5:S644-9. Review.

PMID:
3120274
3.

The role of antibody-mediated immunity in defense against Mycobacterium tuberculosis: advances toward a novel vaccine strategy.

Glatman-Freedman A.

Tuberculosis (Edinb). 2006 May-Jul;86(3-4):191-7. Epub 2006 Apr 3. Review.

PMID:
16584923
4.

[Novel vaccines against M. tuberculosis].

Okada M.

Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.

PMID:
17240920
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk